To cite this paper use one of the standards below:
In this investigation we manufactured and characterized novel polymer derivatives based on poly(2-oxazoline) (POx) covalently linked to partially quaternized chitosan or dextran. These materials are explored for their potential to form stable polymer-DNA polyplexes for ocular gene delivery. The polymers were characterized using proton nuclear magnetic resonance (1HNMR) spectroscopy and size exclusion chromatography (SEC) to confirm their structure and molecular weight. The grafted polysaccharides were employed to complex plasmid DNA at varying nitrogen-to-phosphate (N/P) ratios. Dynamic (DLS) and electrophoretic (ELS) light scattering analyses demonstrated the formation of stable electrostatic complexes with hydrodynamic radius ranging from 40 and 100 nm and a zeta potential of approximately +40 mV, suggesting the formation of stable supramolecular structures. Agarose gel electrophoresis and fluorescence spectroscopy confirmed efficient DNA condensation at N/P ~ 2 for chitosan and N/P ~ 5 for dextran. Biological assays were conducted using retinal pigment epithelial (ARPE-19) and HeLa cells highlighting the versatility of the developed polyplexes for ocular and general gene delivery applications. The MTT assays showed that the polyplexes exhibited low cytotoxicity at biologically relevant concentrations. However, the electrostatic polyplexes alone were inefficient in gene transfection, leading to the incorporation of small aliquots Polyethylenimine (PEI). The addition of a small quantity of PEI resulted in a significant enhancement of transfection efficiency, surpassing the performance of PEI itself at equivalent concentrations. These findings demonstrate the potential of hybrid gene delivery systems that combine natural polymers and PEI to improve the efficacy of polymeric vectors for gene therapy. This research provides critical insights into the development of advanced polymer-based systems for gene therapy, with promising implications in ocular applications.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper